Sunshine Biopharma (SBFM) Depreciation & Amortization - Total: 2019-2025
Historic Depreciation & Amortization - Total for Sunshine Biopharma (SBFM) over the last 6 years, with Sep 2025 value amounting to $95,821.
- Sunshine Biopharma's Depreciation & Amortization - Total rose 48.27% to $95,821 in Q3 2025 from the same period last year, while for Sep 2025 it was $221,550, marking a year-over-year increase of 36.74%. This contributed to the annual value of $146,518 for FY2024, which is 32.35% up from last year.
- Per Sunshine Biopharma's latest filing, its Depreciation & Amortization - Total stood at $95,821 for Q3 2025, which was up 32.11% from $72,533 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Depreciation & Amortization - Total registered a high of $95,821 during Q3 2025, and its lowest value of -$11,597 during Q4 2024.
- Over the past 3 years, Sunshine Biopharma's median Depreciation & Amortization - Total value was $46,744 (recorded in 2024), while the average stood at $45,549.
- Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first spiked by 4,616.10% in 2023, then plummeted by 397.05% in 2024.
- Quarterly analysis of 5 years shows Sunshine Biopharma's Depreciation & Amortization - Total stood at $3,184 in 2021, then spiked by 353.99% to $14,455 in 2022, then crashed by 72.99% to $3,904 in 2023, then crashed by 397.05% to -$11,597 in 2024, then soared by 48.27% to $95,821 in 2025.
- Its Depreciation & Amortization - Total stands at $95,821 for Q3 2025, versus $72,533 for Q2 2025 and $64,793 for Q1 2025.